top of page


We are delighted to announce the publication of a new article on our partner platform the Corporate Social Responsibility and Business Ethics Blog authored by Dr. Costantino Grasso and entitled "The Aspartame Debate: Are Economic Interests Clouding the Truth?"

Aspartame (Sweetener) chemical composition

This article explores the recent reclassification of aspartame, a widely used artificial sweetener, by the World Health Organization (WHO) as “Possibly Carcinogenic to Humans.” The move has stirred varying responses from regulatory bodies, companies, and media outlets, highlighting the complexities that consumers face in discerning fact from opinion in matters of public health.

The United States Food & Drug Administration (FDA) has openly disagreed with WHO’s assessment, while major beverage corporations have shown little inclination to alter their product formulas. Media coverage has further exacerbated the issue by adopting disparate approaches to communicating scientific uncertainty. Beyond the question of the actual toxicity of aspartame, the article underscores the ethical principle surrounding the difficult “predictability” of the harmfulness of certain chemicals. Amid this climate of uncertainty and its potential impact on global health, the article argues for the pressing need for greater transparency, ethical conduct, and responsibility from all parties involved—regulatory agencies, corporations, and the media. It serves as a call for a collective commitment to navigate scientific ambiguities in a manner that prioritizes public welfare.

The article is available at the following link:

Download the article in PDF format:

Costantino Grasso (2023) The Aspartame Debate
Download PDF • 333KB


bottom of page